Somatostatin receptor scintigraphy in advanced renal cell carcinoma
Results of a phase II-trial of somatostatine analogue therapy in patients with advanced RCCSomatostatinrezeptor-Szintigraphie bei fortgeschrittenem NierenzellkarzinomErgebnisse der Phase-IISomatostatinanalogtherapie bei Patienten mit fortgeschrittenem Nierenzellkarzinom
L. S. Freudenberg
1
Department of Nuclear Medicine (Director: Prof. Dr. med. Dr. rer. nat. A. Bockisch)
,
T. Gauler
2
Department of Internal Medicine (Cancer Research) (Director: Prof. Dr. med. Seeber)
,
R. Görges
1
Department of Nuclear Medicine (Director: Prof. Dr. med. Dr. rer. nat. A. Bockisch)
,
S. Bauer
2
Department of Internal Medicine (Cancer Research) (Director: Prof. Dr. med. Seeber)
,
H. Stergar
1
Department of Nuclear Medicine (Director: Prof. Dr. med. Dr. rer. nat. A. Bockisch)
,
G. Antoch
3
Department of Diagnostic and Interventional Radiology and Neuroradiology (Director: Prof. Dr. med. M. Forsting), University of Duisburg-Essen
,
A. Bockisch
1
Department of Nuclear Medicine (Director: Prof. Dr. med. Dr. rer. nat. A. Bockisch)
,
J. Schütte
4
Department of Medical Oncology/Hematology (Director: Prof. Dr. med. J. Schütte), Marien-Hospital Düsseldorf, Germany